A non-interventional, post-authorisation safety study of patients treated with efgartigimod alfa First published 13/03/2024 Last updated 13/03/2024 EU PAS number:EUPAS1000000019 Study Ongoing
United BioSource Corporation (UBC) Switzerland First published:25/04/2013 Last updated 06/03/2024 Institution Non-Pharmaceutical company ENCePP partner